25 November 2017
News and Views
Links and Services
Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction, reports the latest issue of Gastroenterology.
Regular use of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) has been reported
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors